4.5 Article

Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model

Journal

CANCER BIOLOGY & THERAPY
Volume 7, Issue 7, Pages 1033-1036

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cbt.7.7.6037

Keywords

c-jun; cancer; apoptosis; deoxyribozyme; osteosarcoma; liposome

Categories

Funding

  1. Australian Orthopaedics Association
  2. Victorian Orthopaedics Research Trust

Ask authors/readers for more resources

c-jun has been found to be upregulated in a variety of cancers including osteosarcoma. DNAzymes are oligonucleotides capable of specific downregulation of target genes. c-jun knockdown-mediated apoptosis in osteosarcoma cells involved caspases-1, -2 and -8, but not the Fas/FasL pathway. A c-jun DNAzyme, encapsulated within a novel cationic multilamellar vesicle liposome, inhibited the growth and metastasis of osteosarcoma in an orthotopic spontaneously metastasising model of the disease. The 60 nm DDAB: DOPE liposome was formulated using ethanol injection/extrusion. Clinically, downregulation of c-jun may proffer an improved treatment outcome for these tumors originating in bone.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available